Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Weight Heparin in Child-Pugh B Cirrhotic Patients: a Randomized Controlled Study
Phase of Trial: Phase III
Latest Information Update: 27 Jun 2016
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Liver cirrhosis; Thrombosis
- Focus Therapeutic Use
- Acronyms Childbenox
- 16 Jun 2016 Planned End Date changed from 1 Jun 2019 to 1 Jul 2019.
- 16 Jun 2016 Planned primary completion date changed from 1 Jun 2019 to 1 Jul 2019.
- 08 Oct 2015 Planned End Date changed from 1 Apr 2019 to 1 Jun 2019, as reported by ClinicalTrials.gov record.